CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...
Phase 3
Rochester, Minnesota, United States and 18 other locations
Efficacy and safety of ofatumumab and siponimod compared to fingolimod in pediatric patients with multiple sclerosis...
Phase 3
Rochester, Minnesota, United States and 73 other locations
(PK) of RO7303509 treatment in participants with systemic sclerosis (SSc) during a multiple-ascending-dose (MAD) portion of the tri...
Phase 1
Rochester, Minnesota, United States and 42 other locations
ABBV-CLS-7262 is an investigational drug being researched for the treatment of Amyotrophic Lateral Sclerosis. This is an up to 156-week, 2-p...
Phase 1
Rochester, Minnesota, United States and 13 other locations
The purpose of this study is to evaluate the effectiveness and safety of SCONE neuromodulation therapy after 12 weeks of therapy in comparison to ina...
Rochester, Minnesota, United States and 11 other locations
Primary Objective:To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in primary progressive multiple...
Phase 3
Rochester, Minnesota, United States and 291 other locations
Primary Objective:To determine the efficacy of SAR442168 compared to placebo in delaying disability progression in NRSPMSSecondary Objective:To evalu...
Phase 3
Rochester, Minnesota, United States and 300 other locations
The objective of this study is to assess the long-term safety, tolerability, and efficacy of adjunctive therapy of LP352 in subjects with development...
Phase 2
Rochester, Minnesota, United States and 27 other locations
Clinical trials
Research sites
Resources
Legal